SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-057281
Filing Date
2011-10-11
Accepted
2011-10-11 14:46:16
Documents
4
Period of Report
2011-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v236916_8k.htm 8-K 26542
2 EXHIBIT 10.1 v236916_ex10-1.htm EX-10.1 421144
3 EXHIBIT 99.1 v236916_ex99-1.htm EX-99.1 13282
4 GRAPHIC logo.jpg GRAPHIC 6185
  Complete submission text file 0001144204-11-057281.txt   470861
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 111135276
SIC: 4731 Arrangement of Transportation of Freight & Cargo